Free Trial
NYSE:USNA

USANA Health Sciences Q3 2025 Earnings Report

USANA Health Sciences logo
$20.39 +0.13 (+0.64%)
As of 02:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

USANA Health Sciences EPS Results

Actual EPS
$0.56
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

USANA Health Sciences Revenue Results

Actual Revenue
$200.22 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

USANA Health Sciences Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

USANA Health Sciences' Q3 2025 earnings is scheduled for Tuesday, October 28, 2025, with a conference call scheduled on Wednesday, October 22, 2025 at 11:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

USANA Health Sciences Earnings Headlines

The 7 Warning Signals Flashing Red Right Now
A free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. Right now, all seven are flashing red simultaneously for the first time since 2007. These aren't the signals you'll see on CNBC.tc pixel
Why USANA (USNA) Shares Are Trading Lower Today
USANA Health Sciences shares fall on prelim Q3 results
See More USANA Health Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like USANA Health Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your email.

About USANA Health Sciences

USANA Health Sciences (NYSE:USNA) is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America. Key regions of operation include the United States, Canada, China, Taiwan, Australia, the United Kingdom and Mexico. The company leverages a multilevel marketing structure, enabling independent distributors to earn commissions on personal sales and the sales of their recruited team members.

USANA’s manufacturing facilities are located in Salt Lake City, Utah, and in Tlalnepantla, Mexico, providing global production capacity to support demand. The company has emphasized scientific validation of its products and maintains partnerships with third‐party research institutions. Through its focus on health sciences and peer‐reviewed studies, USANA positions itself as a science‐driven provider of wellness solutions.

View USANA Health Sciences Profile

More Earnings Resources from MarketBeat